Toggle navigation
Search
Tree View
MeSH on Demand
MeSH 2023
About
Suggestions
Contact Us
Abiraterone Acetate
MeSH Descriptor Data 2024
Details
Qualifiers
MeSH Tree Structures
Concepts
MeSH Heading
Abiraterone Acetate
Tree Number(s)
D04.210.500.054.079.065
Unique ID
D000069501
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000069501
Scope Note
An androstene derivative that inhibits
STEROID 17-ALPHA-HYDROXYLASE
and is used as an
ANTINEOPLASTIC AGENT
in the treatment of metastatic castration-resistant
PROSTATE CANCER
.
Entry Term(s)
17-(3-pyridyl)-5,16-androstadien-3beta-acetate
CB 7630
CB-7630
CB7630
Zytiga
Pharm Action
Antineoplastic Agents
Steroid Synthesis Inhibitors
Cytochrome P-450 Enzyme Inhibitors
Registry Number
EM5OCB9YJ6
Related Numbers
154229-18-2
Public MeSH Note
2016; ABIRATERONE ACETATE was indexed under ANDROSTENES 1994-2015
History Note
2016 (1994)
Date Established
2016/01/01
Date of Entry
2015/07/09
Revision Date
2016/05/27
Allowable Qualifiers
administration & dosage (AD)
adverse effects (AE)
agonists (AG)
analogs & derivatives (AA)
analysis (AN)
antagonists & inhibitors (AI)
blood (BL)
cerebrospinal fluid (CF)
chemical synthesis (CS)
chemistry (CH)
classification (CL)
economics (EC)
history (HI)
immunology (IM)
isolation & purification (IP)
metabolism (ME)
pharmacokinetics (PK)
pharmacology (PD)
poisoning (PO)
radiation effects (RE)
standards (ST)
supply & distribution (SD)
therapeutic use (TU)
toxicity (TO)
urine (UR)
Polycyclic Compounds [D04]
Fused-Ring Compounds [D04.210]
Steroids [D04.210.500]
Androstanes [D04.210.500.054]
Androstenes [D04.210.500.054.079]
Abiraterone Acetate [D04.210.500.054.079.065]
Androstadienes [D04.210.500.054.079.129]
Androstatrienes [D04.210.500.054.079.229]
Androstenedione [D04.210.500.054.079.329]
Androstenols [D04.210.500.054.079.429]
Finasteride [D04.210.500.054.079.500]
Expand All
Collapse All
Abiraterone Acetate
Preferred
Concept UI
M0562608
Registry Number
EM5OCB9YJ6
Related Numbers
154229-18-2
Scope Note
An androstene derivative that inhibits
STEROID 17-ALPHA-HYDROXYLASE
and is used as an
ANTINEOPLASTIC AGENT
in the treatment of metastatic castration-resistant
PROSTATE CANCER
.
Terms
Abiraterone Acetate
Preferred Term
Term UI
T000880469
Date
05/26/2015
LexicalTag
NON
ThesaurusID
17-(3-pyridyl)-5,16-androstadien-3beta-acetate
Narrower
Concept UI
M0237234
Registry Number
154229-18-2
Terms
17-(3-pyridyl)-5,16-androstadien-3beta-acetate
Preferred Term
Term UI
T267239
LexicalTag
NON
ThesaurusID
NLM (1994)
Zytiga
Narrower
Concept UI
M0579770
Registry Number
0
Terms
Zytiga
Preferred Term
Term UI
T834678
Date
12/20/2012
LexicalTag
TRD
ThesaurusID
CB 7630
Narrower
Concept UI
M0237237
Registry Number
0
Terms
CB 7630
Preferred Term
Term UI
T267242
LexicalTag
LAB
ThesaurusID
NLM (1994)
CB-7630
Term UI
T267240
LexicalTag
LAB
ThesaurusID
NLM (1994)
CB7630
Term UI
T267241
LexicalTag
LAB
ThesaurusID
NLM (1994)
page delivered in 0.157s